U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07482384) titled 'Supporting Health Including Endocrine Treatment for Long Duration' on March 16.
Brief Summary: This research is being done to pilot an intervention which aims to test a new web- and mobile application ("app")-based supportive care tool (SHIELD portal) and to assess the feasibility of enrolling female breast cancer patients with hormone receptor-positive disease long-term endocrine treatment.
Study Start Date: May, 2026
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
Breast Cancer - Female
Breast Carcinoma
ER Positive Breast Cancer
PR-Positive Breast Cancer
Intervention:
BEHAVIORAL: SHIELD portal
All participants will rec...